SP Funds Trust SP Funds S&P Global Technology ETFの空売り状況は、投資家がSP Funds Trust SP Funds S&P Global Technology ETFの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

SP Funds Trust SP Funds S&P Global Technology ETF (ARCA:SPTE), 空売り情報

The Fund uses a passive management (or indexing) approach to track the performance, before fees and expenses, of the Index. The S&P Global 1200 Shariah Information Technology Capped Index is designed to measure the performance of global large-cap equity securities within the information technology sector that pass rules-based screens for adherence to Shariah investment guidelines, with a cap applied to ensure diversification among companies in the Index..

Taiwan Semiconductor Manufacturing Co. Ltd. Adr ( Tsm )

Nvidia Corp.

Microsoft Corp

Apple Inc

Asml Holding Nv

Sap S.e., ADR

Broadcom Inc

Tokyo Electron Ltd Unspn Adr

Keyence Corp

Shopify Inc.

SP Funds S&P Global Technology ETF

SP Funds Trust SP Funds S&P Global Technology ETF

Xtant Medical Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/XTNT#AMEX">XTNT</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $31.51 million which missed the analyst consensus estimate of $31.80 million by 0.90 percent. This is a 12.11 percent increase over sales of $28.11 million the same period last year.

Earnings

Earnings Misses

News

XTNT

Xtant Medical Hldgs Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $31.51M Miss $31.80M Estimate

Profound Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROF#NASDAQ">PROF</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.33) by 39.39 percent. This is a 52.38 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $4.18 million which missed the analyst consensus estimate of $4.27 million by 2.10 percent. This is a 108.85 percent increase over sales of $2.00 million the same period last year.

Earnings Beats

PROF

Profound Medical Q4 EPS $(0.20) Beats $(0.33) Estimate, Sales $4.18M Miss $4.27M Estimate

WIIM

NDLS

Noodles shares are trading higher after the company issued FY25 guidance above estimates.

CLAR

Clarus Q4 2024 Adj. EPS $(0.08) Misses $0.07 Estimate, Sales $71.4M Beat $69.028M Estimate

Guidance

Cooper Companies Sees FY25 Adj. EPS $3.94-$4.02 Vs $3.98 Est.; Revenue $4.080B-$4.158B Vs $4.121B Est.

ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.67) by 34.33 percent. This is a 44.3 percent increase over losses of $(0.79) per share from the same period last year.

ALXO

ALX Oncology Holdings Q4 2024 Adj EPS $(0.44) Beats $(0.67) Estimate

AVGO

Broadcom shares are trading higher following better-than-expected Q1 financial results and strong Q2 guidance.

Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) reported quarterly earnings of $4.02 per share which missed the analyst consensus estimate of $4.10 by 1.95 percent. This is a 8.36 percent increase over earnings of $3.71 per share from the same period last year. The company reported quarterly sales of $63.72 billion which beat the analyst consensus estimate of $63.13 billion by 0.93 percent. This is a 9.04 percent increase over sales of $58.44 billion the same period last year.

COST

Costco Wholesale Q2 Adj $4.02 Misses $4.10 Estimate, Sales $63.72B Beat $63.13B Estimate

ARCT

Arcturus Therapeutics shares are trading lower after the company reported Q4 financial results and missed its EPS and revenue estimates.

Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) sees FY2025 sales of $503.000 million-$512.000 million vs $494.43 million analyst estimate.

Noodles Sees FY2025 Sales $503.000M-$512.000M vs $494.43M Est

Broadcom Sees Q2 Revenue ~$14.9B vs $14.762B Est., Sees Q2 Adj. EBITDA ~66% Of Projected Revenue

Cooper Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COO#NYSE">COO</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.91 by 1.1 percent. This is a 8.24 percent increase over earnings of $0.85 per share from the same period last year. The company reported quarterly sales of $964.700 million which missed the analyst consensus estimate of $978.091 million by 1.37 percent. This is a 3.55 percent increase over sales of $931.600 million the same period last year.

Cooper Companies Q1 2025 Adj. EPS $0.92 Beats $0.91 Estimate, Sales $964.700M Miss $978.091M Estimate

WLDN

Willdan Group shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY25 guidance above estimates.

&nbsp;New York, NY, March 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GLLI#OTC">GLLI</a>, GLLIW, GLLIR, GLLIU))) ("Globalink" or the "Company"), a special purpose acquisition company, announced today that on March 6, 2025, it caused to be deposited $60,000 (the "Extension Payment") into its trust account (the "Trust Account") with Continental Stock Transfer and Trust Company ("Continental") to extend the deadline to complete its initial business combination from March 9, 2025 to April 9, 2025. The extension is the twenty-first extension since the consummation of the Company's initial public offering on December 9, 2021, and the fourth of up to six extensions permitted under the Company's governing documents currently in effect.

GLLI

Globalink Investment Announces Extension Of Deadline To Complete A Business Combination To March 9, 2025

Broadcom Q1 2025 Adj. EPS $1.60 Beats $1.49 Estimate, Sales $14.916B Beat $14.610B Estimate

Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.12) by 25 percent. This is a 114.29 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $121.77 million which missed the analyst consensus estimate of $122.01 million by 0.20 percent. This is a 2.05 percent decrease over sales of $124.32 million the same period last year.

Noodles Q4 Adj $(0.15) Misses $(0.12) Estimate, Sales $121.77M Miss $122.01M Estimate

Atea Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVIR#NASDAQ">AVIR</a>) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.37) by 8.11 percent. This is a 14.89 percent increase over losses of $(0.47) per share from the same period last year.

AVIR

Atea Pharmaceuticals Q4 EPS $(0.40) Misses $(0.37) Estimate

Samsara shares are trading lower. The company reported Q4 financial results.

Willdan Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLDN#NASDAQ">WLDN</a>) is looking for FY2025 Adj EPS of $2.70-$2.85 vs $2.35 analyst estimate. sees sales of $320.000 million-$330.000 million vs $313.90 million analyst estimate.

Willdan Group Sees FY2025 Adj EPS $2.70-$2.85 vs $2.35 Est; Sees Sales $320.000M-$330.000M vs $313.90M Est

HPE estimates fiscal 2025 GAAP operating profit growth to be in the range of negative 24% to negative 9% and non-GAAP operating profit growth to be negative 10% to 0%.
&nbsp;

Comments

SP Funds Trust SP Funds S&P Global Technology ETF

空売り

SP Funds Trust SP Funds S&P Global Technology ETF (ARCA:SPTE), 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル